Publication: 4024

Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension.
      QxMD      Google Scholar   
Citation:
Pharmacogenomics J vol 24 (4) 22
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233341, UG1CA233373  
Corr. Author:
 
Authors:
       
Networks:
LAPS-NC007   
Study
Alliance-A152114
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-90401
Phases:
N/A, 3
Keywords: